Israel acts on drug imports to cut healthcare bills
BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7249.1562/c (Published 10 June 2000) Cite this as: BMJ 2000;320:1562- Judy Siegel-Itzkovich
- Jerusalem
Israel is to open up its drugs industry to free market competition in order to drive down medical costs. Despite massive opposition by US pharmaceutical companies and government officials—including Secretary of State Madeleine Albright—Israel has agreed to allow the import of many prescription only and over the counter drugs from September. Experts in Israel's health ministry and the country's largest public health insurer, Clalit Health Services (CHS), predict that the opening of drug imports to competition will save the public health insurers and hospitals tens of millions of dollars a year.
Until now, Israel has been one of the few places in the world to honour exclusivity contracts between drug …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.